33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2135679
178559
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Obtener premium
Create a timeline
Public timelines
FAQ
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate

16 mayo 2018 año - FDA approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for the mitigation of withdrawal symptoms associated with abrupt discontinuation of opioids.

Añadido al timeline:

Opioids and the FDA

ByAnastasia
13 nov 2018
0
0
523

fecha:

16 mayo 2018 año
Ahora mismo
~ 7 years and 5 months ago
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL